Dolf Boerman
Impact in
- Genetics top 1%
- Glioma Diagnosis and Treatment
-
- Cancer, Hypoxia, and Metabolism
Papers in
- Genetics 3
- Glioma Diagnosis and Treatment 3
-
- Musculoskeletal pain and rehabilitation 1
- Co-authors
- Martin J. van den Bent (4 shared papers)Roelien H. Enting (2 shared papers)Monique C.J. Hanse (3 shared papers)Jacoline E. C. Bromberg (3 shared papers)Franchette W.P.J. van den Berkmortel (3 shared papers)René M. Vernhout (3 shared papers)Walter Taal (3 shared papers)Hendrika M. Oosterkamp (3 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)The Lancet Oncology (1 paper)Journal of Occupational Rehabilitation (1 paper)Neurology (1 paper)Neuro-Oncology (1 paper)
- Partner nations
- NetherlandsUnited StatesCuracao
In The Last Decade
Dolf Boerman
7 papers receiving 907 citations
Dolf Boerman's Hit Papers
Peers
Comparison fields: 5 of 65
- Genetics 612
- Cancer Research 136
- Pulmonary and Respiratory Medicine 251
- Neurology 84
- Oncology 102
Countries citing papers authored by Dolf Boerman
This map shows the geographic impact of Dolf Boerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dolf Boerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dolf Boerman more than expected).
Fields of papers citing papers by Dolf Boerman
This network shows the impact of papers produced by Dolf Boerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dolf Boerman. The network helps show where Dolf Boerman may publish in the future.
Co-authors
The 25 scholars most cited alongside Dolf Boerman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial Hit paper breakdown → | 2014 | 573 |
| 2 | 2009 | 257 | |
| 3 | 2013 | 44 | |
| 4 | 2006 | 31 | |
| 5 | 2021 | 12 | |
| 6 | 2019 | 9 | |
| 7 | 2014 | 3 |
About Dolf Boerman
Dolf Boerman is a scholar working on Genetics, Pharmacology, Pulmonary and Respiratory Medicine, Oncology and Epidemiology, having authored 7 papers that have together received 929 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (3 papers), Cancer, Hypoxia, and Metabolism (1 paper), Trypanosoma species research and implications (1 paper), Fibromyalgia and Chronic Fatigue Syndrome Research (1 paper), Musculoskeletal pain and rehabilitation (1 paper), Research on Leishmaniasis Studies (1 paper), Cancer Treatment and Pharmacology (1 paper) and Brain Metastases and Treatment (1 paper). The work is most often cited by research in Genetics (612 citations), Cancer Research (136 citations), Pulmonary and Respiratory Medicine (251 citations), Neurology (84 citations) and Oncology (102 citations). Dolf Boerman has collaborated with scholars based in Netherlands, United States and Curacao. Frequent co-authors include Martin J. van den Bent, Roelien H. Enting, Monique C.J. Hanse, Jacoline E. C. Bromberg, Franchette W.P.J. van den Berkmortel, René M. Vernhout, Walter Taal, Hendrika M. Oosterkamp, Bronno van der Holt and Irene van Heuvel. Their work appears in journals such as Journal of Clinical Oncology, The Lancet Oncology, Journal of Occupational Rehabilitation, Neurology and Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.